# 📚 Testing Regimen Documentation Index

**Strategy**: Intraday Alpha V1.0 (Laminar DNA)  
**Prepared**: January 24, 2026  
**Status**: AWAITING APPROVAL TO PROCEED

---

## 📁 Document Suite Overview

This directory contains a comprehensive testing regimen designed to validate the Intraday Alpha strategy for potential reactivation and live capital deployment. The testing framework follows **Magellan's Institutional Validation Standard (IVS)** and consists of **6 phases, 19 specific tests, and 14 deployment gates**.

---

## 🗂️ Available Documents

### 1️⃣ **TESTING_REGIMEN_PROPOSAL.md** (Main Technical Document)
**Purpose**: Comprehensive technical specification of the entire testing framework  
**Length**: ~600 lines  
**Audience**: Quantitative analysts, strategy developers, testing engineers

**Contents**:
- Executive summary with risk assessment
- Detailed specifications for all 19 tests across 6 phases
- Success criteria and failure indicators for each test
- Testing infrastructure and tooling requirements
- Known risks and mitigation strategies
- 4-week execution timeline with milestones
- References to Magellan validation standards

**When to Use**: 
- Detailed test design and implementation
- Understanding rationale behind each test
- Developing test scripts and infrastructure
- Debugging test failures

---

### 2️⃣ **TESTING_SUMMARY_EXECUTIVE.md** (Executive Brief)
**Purpose**: High-level overview for decision-makers and stakeholders  
**Length**: ~400 lines  
**Audience**: Risk managers, portfolio managers, executives

**Contents**:
- One-sentence summary of entire regimen
- Critical risk assessment (red flags + strengths)
- Visual testing roadmap with gates
- Success criteria summary table
- Deployment decision matrix
- Strategic insights and hypotheses
- Expected outcomes (probability estimates)
- Key metrics to watch during testing

**When to Use**:
- Executive presentations and briefings
- Initial approval and funding requests
- Status updates to non-technical stakeholders
- Quick reference for testing phases

---

### 3️⃣ **TESTING_CHECKLIST.md** (Operational Tracker)
**Purpose**: Working document for tracking test execution and recording results  
**Length**: ~450 lines  
**Audience**: Testing analysts, project managers

**Contents**:
- Phase-by-phase checklists with checkboxes
- Result recording tables (fill-in-the-blank)
- Pass/fail status indicators
- Daily logs for paper trading phase
- Final GO/NO-GO decision template
- Post-decision action items

**When to Use**:
- Day-to-day test execution tracking
- Recording actual test results as they're generated
- Progress reporting in team meetings
- Final deployment decision documentation

---

### 4️⃣ **README.md** (Strategy Background)
**Purpose**: Historical context and strategy documentation  
**Already Exists**: Yes (original documentation)

**Contents**:
- Strategy overview (V1.0 "Laminar DNA")
- Multi-factor alpha calculation logic
- Symbol configuration (SPY/QQQ/IWM)
- Risk controls and position sizing
- Original deployment details (Jan 10, 2026)
- Why this version was replaced (Jan 11, 2026)

---

### 5️⃣ **This Document - TESTING_INDEX.md**
**Purpose**: Navigation guide and document relationships  
**You are here!** 👈

---

## 🎯 Quick Start Guide

### For Strategy Owners / Decision Makers:
1. **Start Here**: Read `TESTING_SUMMARY_EXECUTIVE.md` (15 min)
2. **Review Questions**: Answer the 5 strategic questions at the end
3. **Decision Point**: Approve/modify/reject the testing proposal
4. **Next Step**: Authorize Phase 1 execution

### For Quantitative Analysts / Testers:
1. **Start Here**: Read `TESTING_REGIMEN_PROPOSAL.md` (45 min)
2. **Understand Context**: Review `README.md` for strategy details
3. **Plan Work**: Use `TESTING_CHECKLIST.md` to organize tasks
4. **Develop Tests**: Build the 7 required scripts (Phase 1-4 tests)
5. **Execute**: Run tests, record results in checklist
6. **Report**: Summarize findings for decision meeting

### For Risk Managers:
1. **Start Here**: Read "Critical Risk Assessment" section in `TESTING_SUMMARY_EXECUTIVE.md`
2. **Deep Dive**: Review Phase 2 (Adversarial Testing) in `TESTING_REGIMEN_PROPOSAL.md`
3. **Focus Areas**: 
   - Friction burden calculation (Test 4.1)
   - Parameter stability (Test 2.2)
   - Multi-regime stress (Test 1.2)
4. **Gates**: Verify all 14 deployment gates are appropriate for risk tolerance

---

## 🔑 Key Concepts & Terminology

**IVS (Institutional Validation Standard)**: Magellan's proprietary framework for strategy validation, requiring 7-pillar testing, multi-regime stress, and adversarial perturbations before deployment.

**WFA-C (Walk-Forward Analysis - Consistency)**: The 3/4 Reliability Heuristic—strategy must be profitable in ≥3 of 4 years (2022-2025) to pass.

**Frequency-Friction Death Spiral**: High-frequency strategies can consume >100% of capital in friction costs if trade frequency × slippage exceeds return generation capacity. Threshold: 15% annual friction.

**Sentry Gate**: Sentiment threshold that kills alpha score if market sentiment falls below configured level (e.g., 0.0 for SPY = no long entries in bearish sentiment).

**Neighboring Stability**: Parameter robustness test—if only the exact baseline parameters are profitable and all variants fail, strategy is "overfitted to a parameter island."

**Breakeven Friction**: Exact slippage level (in bps) where strategy PnL crosses zero. Critical metric for production viability.

**+1 Bar Lag**: Realistic execution model where signal is generated on bar N close but fill occurs on bar N+1 open (prevents look-ahead bias).

**Sharpe Collapse**: Dramatic drop in Sharpe Ratio when testing period extends (e.g., 2.0 Sharpe in 30 days → 0.3 Sharpe in 252 days). Indicator of recency bias/regime luck vs. structural edge.

---

## 📊 Testing Framework Architecture

```
┌─────────────────────────────────────────────────────────┐
│  PHASE 1: HISTORICAL TRUTH                             │
│  "Did it EVER work?"                                   │
│  ├─ Test 1.1: 2024-2025 Baseline                      │
│  ├─ Test 1.2: 2022-2025 Multi-Regime                  │
│  └─ Test 1.3: Data Integrity Audit                    │
│  🚦 GATE: If <3/9 gates pass → EARLY KILL             │
└─────────────────────────────────────────────────────────┘
                          ↓
┌─────────────────────────────────────────────────────────┐
│  PHASE 2: ADVERSARIAL STRESS                           │
│  "Where does it BREAK?"                                │
│  ├─ Test 2.1: Friction Ladder (5-20 bps)              │
│  ├─ Test 2.2: Parameter Stability (neighbors)         │
│  ├─ Test 2.3: Timing Shift (+1/+2/+3 bars)            │
│  └─ Test 2.4: Sentiment Oracle (dependency)           │
│  🚦 GATE: Must survive 10 bps friction                 │
└─────────────────────────────────────────────────────────┘
                          ↓
┌─────────────────────────────────────────────────────────┐
│  PHASE 3: STATISTICAL PROOF                            │
│  "Is it LUCK or SKILL?"                                │
│  ├─ Test 3.1: Monte Carlo Shuffling                   │
│  ├─ Test 3.2: Win Rate Significance                   │
│  └─ Test 3.3: Bootstrap CI                            │
│  🚦 GATE: Must be >75th percentile vs. random          │
└─────────────────────────────────────────────────────────┘
                          ↓
┌─────────────────────────────────────────────────────────┐
│  PHASE 4: INTRADAY VULNERABILITIES                     │
│  "Can it survive REAL execution?"                      │
│  ├─ Test 4.1: Frequency-Friction Audit                │
│  ├─ Test 4.2: Session Performance                     │
│  └─ Test 4.3: Latency Simulation                      │
│  🚦 GATE: Annual friction <15% of capital              │
└─────────────────────────────────────────────────────────┘
                          ↓
┌─────────────────────────────────────────────────────────┐
│  PHASE 5: LIVE PAPER TRADING                           │
│  "Does it EXECUTE cleanly?"                            │
│  ├─ Test 5.1: 10-Day Forward Test                     │
│  ├─ Test 5.2: Kill-Switch Validation                  │
│  └─ Test 5.3: Circuit Breakers                        │
│  🚦 GATE: Fill rate >95%, Slippage ≤5 bps             │
└─────────────────────────────────────────────────────────┘
                          ↓
┌─────────────────────────────────────────────────────────┐
│  PHASE 6: GO/NO-GO DECISION                            │
│  All 14 gates reviewed → APPROVED/CONDITIONAL/REJECT   │
└─────────────────────────────────────────────────────────┘
```

---

## 📈 Success Metrics Summary

### Quantitative Requirements (9 Gates)
1. **Sharpe >1.0** (4-year composite)
2. **Win Rate >45% AND p<0.05** (statistical significance)
3. **3/4 Year Profitability** (2022, 2023, 2024 out of 4 years)
4. **Profitable at 10 bps friction** (2x stress test)
5. **Annual Friction <15%** (death spiral prevention)
6. **Max Drawdown <20%** (any single year)
7. **Parameter Stability ≥70%** (neighboring parameters profitable)
8. **Trade Count >100/year** (statistical significance)
9. **Profit Factor >1.3** (gross wins / gross losses)

### Qualitative Requirements (5 Gates)
10. **Paper Trading Success** (2 weeks, fill >95%, slip ≤5 bps)
11. **Sentiment Independence** (viable without perfect sentiment data)
12. **Infrastructure Ready** (latency <100ms, uptime >99.5%)
13. **Code Audit** (production-grade, no hardcoded values)
14. **Operational Runbook** (documented procedures)

---

## ⏱️ Timeline Summary

| Week | Phase | Deliverable |
|------|-------|-------------|
| **Week 1** | Phase 1 + 2 | Preliminary Report (early kill if critical failures) |
| **Week 2** | Phase 3 + 4 | Comprehensive Test Report (GO/NO-GO for paper) |
| **Week 3** | Phase 5 | Daily paper trading logs |
| **Week 4** | Phase 6 | Final deployment decision + production prep |

**Total Duration**: 4 weeks from approval to deployment decision

---

## 🚨 Critical Decision Points

### Early Kill Gate (End of Week 1)
**Trigger**: If strategy fails ≥7 of 9 quantitative gates in Phase 1-2  
**Action**: Stop testing, archive strategy, document lessons learned  
**Rationale**: Don't waste Week 3-4 on fundamentally broken strategy

### Paper Trading Go/No-Go (End of Week 2)
**Trigger**: If strategy passes ≥9 of 14 gates in Phase 1-4  
**Action**: Proceed to Phase 5 (paper trading)  
**Rationale**: Only test in live market if backtests are promising

### Final Deployment Decision (End of Week 4)
**Outcomes**:
- **APPROVED**: All 14 gates passed → $100k capital allocation
- **CONDITIONAL**: 11-13 gates passed → $50k capital + weekly review
- **PAPER-ONLY**: 9-10 gates passed → Extended 60-day paper test
- **REJECTED**: <9 gates passed → Archive strategy

---

## 📞 Questions & Support

### Strategic Questions (Awaiting Answers):
1. **Sentiment Data**: Do we have historical sentiment data for SPY/QQQ/IWM (2022-2026)?
2. **Deployment Intent**: Reactivate as-is, baseline for improvements, or academic exercise?
3. **Capital Allocation**: If approved, what initial allocation is acceptable ($25k/$50k/$100k/$200k)?
4. **Risk Tolerance**: Daily loss limit? Max position duration? Consecutive loss halt?
5. **Timeline Flexibility**: Is 4-week timeline acceptable or is there urgency?

### Technical Support:
- **Lead Contact**: Antigravity AI (Quantitative Testing Strategist)
- **Documentation Issues**: File in this directory's issue tracker
- **Testing Script Development**: See `TESTING_REGIMEN_PROPOSAL.md` Section: "Testing Infrastructure & Tooling"

---

## 🔗 Related Documentation

### Magellan Knowledge Base:
- **Intraday Alpha Strategy Track (Track 4)**: Full lifecycle and historical context
- **Magellan Quantitative Validation Protocols**: IVS standards and 7-Pillar methodology
- **Magellan System Architecture**: Infrastructure capabilities and constraints

### External Standards:
- **IVS (Institutional Validation Standard)**: Jan 19, 2026
- **V-ADS (Adversarial Audit & Perturbation Standard)**: Jan 19, 2026
- **Frequency-Friction Bounds Protocol**: Jan 16, 2026
- **WFA-C (Walk-Forward Consistency) Standard**: Jan 20, 2026

---

## ✅ Approval & Sign-off

**Testing Regimen Prepared By**: Antigravity AI  
**Preparation Date**: January 24, 2026  
**Status**: ⬜ PENDING APPROVAL

**Approval Sign-offs**:
- [ ] Strategy Owner: _________________ Date: _______
- [ ] Risk Manager: _________________ Date: _______
- [ ] Quantitative Lead: _________________ Date: _______

**Approval to Proceed with Phase 1**: ⬜ APPROVED / ⬜ MODIFIED / ⬜ REJECTED

**Authorized Capital (if approved)**: $_____________

**Testing Start Date**: _____________

---

## 📝 Revision History

| Date | Version | Changes | Author |
|------|---------|---------|--------|
| 2026-01-24 | 1.0 | Initial testing regimen proposal | Antigravity AI |
| | | | |
| | | | |

---

**Status**: ✅ DOCUMENTATION COMPLETE - READY FOR REVIEW  
**Next Action**: Strategy owner reviews and approves/modifies/rejects testing plan
